Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Sell
2,127
-683
-24% -$123K 0.04% 217
2025
Q4
$521K Buy
2,810
+900
+47% +$168K 0.05% 188
2025
Q3
$385K Buy
+1,910
New +$393K 0.04% 204
2023
Q4
Sell
-6,307
Closed -$1.2M 292
2023
Q3
$1.2M Buy
6,307
+446
+8% +$85.5K 0.14% 118
2023
Q2
$1.1M Buy
5,861
+1,839
+46% +$326K 0.13% 118
2023
Q1
$670K Sell
4,022
-954
-19% -$159K 0.08% 143
2022
Q4
$823K Buy
4,976
+305
+7% +$49.9K 0.11% 122
2022
Q3
$697K Buy
4,671
+356
+8% +$57.1K 0.1% 127
2022
Q2
$670K Buy
4,315
+407
+10% +$65.2K 0.09% 136
2022
Q1
$666K Sell
3,908
-463
-11% -$73K 0.09% 139
2021
Q4
$760K Buy
4,371
+768
+21% +$128K 0.09% 124
2021
Q3
$546K Buy
3,603
+1,569
+77% +$237K 0.08% 138
2021
Q2
$286K Buy
+2,034
New +$273K 0.04% 180

Other funds holding MRSH

Stokes Family Office's MRSH Position: Q1 2026 in Review

Stokes Family Office reduced its Marsh (MRSH) stake by 24% in Q1 2026, selling an estimated $123K and leaving 2,127 shares worth $369K. The position accounts for 0.04% of the portfolio, ranked #217.

Stokes Family Office first reported a position in MRSH in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.2M in Q3 2023. 1,536 funds tracked by Wall St. Rank hold MRSH as of Q1 2026.

  • Stokes Family Office held 2,127 shares of Marsh worth $369K as of Q1 2026.
  • Stokes Family Office sold 683 Marsh shares in Q1 2026, an estimated $123K.
  • Marsh made up 0.04% of Stokes Family Office's portfolio in Q1 2026, its #217 holding.
  • Stokes Family Office first reported a position in Marsh in Q2 2021 and has held it in 13 quarters since.
  • Stokes Family Office's Marsh position peaked at $1.2M in Q3 2023.
  • 1,536 funds tracked by Wall St. Rank held Marsh as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.